FDA Advisors OK Approval of First Over-the-Counter Birth Control Pill
WEDNESDAY, May 10, 2023 (HealthDay News) — In a unanimous vote, a panel of expert advisors to the U.S. Food and Drug Administration on Wednesday endorsed the over-the-counter sale of a birth control pill, a recommendation that will likely pave the wa…
Learn MoreUnos expertos de la FDA sopesarán la primera pastilla anticonceptiva de venta libre
MARTES, 9 de mayo de 2023 (HealthDay News) — Mientras un panel asesor de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. sopesa si recomendar o no que una pastilla anticonceptiva se venda sin receta en este país, una coalición de defen…
Learn MoreFDA Experts to Consider First Over-the-Counter Birth Control Pill
TUESDAY, May 9, 2023 (HealthDay News) — As a U.S. Food Drug Administration advisory panel prepares to weigh whether to recommend that a birth control pill be sold over the counter in this country, a coalition of advocates on Monday called attention t…
Learn MoreFDA Experts to Consider First Over-the-Counter Birth Control Pill
TUESDAY, May 9, 2023 (HealthDay News) — As a U.S. Food Drug Administration advisory panel prepares to weigh whether to recommend that a birth control pill be sold over the counter in this country, a coalition of advocates on Monday called attention t…
Learn MoreMany Older Americans Would Like to Take Fewer Meds, Poll Reveals
TUESDAY, April 25, 2023 (HealthDay News) — Americans older than 50 years are interested in cutting back on prescription medications, dovetailing with a movement toward “deprescribing,” according to the results of the latest University of Michigan Nat…
Learn MoreVacations Are No Time to Take a Holiday From Allergy & Asthma Treatments
WEDNESDAY, April 19, 2023 (HealthDay News) — Summer is almost here, and its arrival brings opportunities for many people – including those who suffer with allergies and asthma — to plan vacations away from home.A recent article titled “Allergies don’…
Learn MoreFDA Approves First Over-the-Counter Nasal Spray for Opioid Overdoses
WEDNESDAY, March 29, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the over-the-counter (OTC) use of naloxone (Narcan).”Today’s approval of OTC naloxone nasal spray will help improve access to naloxone, increase …
Learn MoreNirmatrelvir Cuts Risk for Post-COVID-19 Condition
MONDAY, March 27, 2023 (HealthDay News) — Treatment with nirmatrelvir during the acute phase of COVID-19 may reduce the risk for postacute adverse health outcomes, according to a study published online March 23 in JAMA Internal Medicine.Yan Xie, Ph.D…
Learn MoreUn panel de la FDA reevaluará el mérito de un descongestionante que muchos califican de inútil
LUNES, 6 de marzo de 2023 (HealthDay News) — Hace años que los consumidores utilizan un descongestionante oral de venta libre llamado fenilefrina, pero quizá esta situación no continúe mucho tiempo.La Administración de Alimentos y Medicamentos (FDA) …
Learn MoreFDA Panel to Again Weigh Merit of Decongestant That Many Call Useless
MONDAY, March 6, 2023 (HealthDay News) — Consumers have been using the common over-the-counter oral decongestant phenylephrine for years, but that may not continue much longer. The U.S. Food and Drug Administration has asked a panel of its advisers t…
Learn More